News | April 23, 2014

Swiss Researchers Use Focused Ultrasound Waves to Treat Brain Tumor

April 23, 2014 — Researchers in Zurich, Switzerland, have successfully used focused ultrasound for the first time to noninvasively ablate part of a recurrent glioma tumor through a patient’s intact skull. The procedure was performed to assess the feasibility and safety of focused ultrasound in treating brain tumors; it was not intended to demonstrate efficacy. The procedure was conducted using InSightec's Exablate Neuro system.

Focused ultrasound employs thousands of ultrasound beams that converge on a spot deep in the body. At this focal point, the ultrasound can cause a variety of biological effects — in this case, heat and destroy the cancerous tissue.

The treatment was conducted at the Focused Ultrasound Center of University Children's Hospital Zurich by a team led by Javier Fandino, M.D., professor of neurosurgery at Kantonsspital Aarau, Switzerland, and Ernst Martin, M.D., professor of neuroradiology, University Children’s Hospital Zurich.

"The patient was awake and responsive during the treatment, and we were able to successfully target and destroy a part of the tumor located deep within the patient's brain,” said Fandino. “We are very encouraged that we could utilize focused ultrasound to accomplish this with no side effects or complications."

"The ability of focused ultrasound to accomplish both small lesions for functional neurosurgery as well as bulk lesions for tumor ablation is amazing," added Martin.

There is an urgent need for new approaches to treating brain tumors. With its ability to noninvasively and accurately target and destroy diseased areas while sparing healthy adjacent brain tissue, focused ultrasound could prove to be a breakthrough.

“Treatment of this patient is the first critical step in the path to developing a new, noninvasive approach for patients with brain tumors that could serve as an alternative to surgery or radiation therapy,” said Neal F. Kassell, M.D., chairman of the Focused Ultrasound Foundation. “Additional clinical trials to prove safety and efficacy are required to translate this milestone into a treatment that could improve the quality of life and longevity for countless individuals.”

Focused ultrasound is an early-stage therapeutic technology with the potential to transform the treatment of many serious medical disorders. This technology uses ultrasonic energy guided by magnetic resonance (MR) or ultrasound imaging to treat tissue deep in the body without incisions or radiation. Multiple intersecting beams of ultrasound are directed and concentrated on a target as small as a grain of rice. The Focused Ultrasound Foundation was created to accelerate the development and adoption of focused ultrasound therapies.

For more information: www.fusfoundation.org

Related Content

Digital Mammography Increases Breast Cancer Detection
News | Mammography | January 16, 2019
The shift from film to digital mammography increased the detection of breast cancer by 14 percent overall in the United...
MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Artificial Intelligence Used in Clinical Practice to Measure Breast Density
News | Artificial Intelligence | January 15, 2019
An artificial intelligence (AI) algorithm measures breast density at the level of an experienced mammographer,...
Machine Learning Uncovers New Insights Into Human Brain Through fMRI
News | Neuro Imaging | January 11, 2019
An interdisciplinary research team led by scientists from the National University of Singapore (NUS) has successfully...
Mobile App Data Collection Shows Promise for Population Health Surveys
News | Population Health | January 10, 2019
Mobile app data collection can bring access to more potential clinical study participants, reduce clinical study...
Hypertension With Progressive Cerebral Small Vessel Disease Increases Cognitive Impairment Risk
News | Magnetic Resonance Imaging (MRI) | January 08, 2019
Patients with high blood pressure and progression of periventricular white matter hyperintensities showed signs of...
Artificial Intelligence Pinpoints Nine Different Abnormalities in Head Scans

A brain scan (left) showing an intraparenchymal hemorrhage in left frontal region and a scan (right) of a subarachnoid hemorrhage in the left parietal region. Both conditions were accurately detected by the Qure.ai tool. Image courtesy of Nature Medicine.

News | Artificial Intelligence | January 07, 2019
The rise in the use of computed tomography (CT) scans in U.S. emergency rooms has been a well-documented trend1 in...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
Breast Cancer Patients Have Less Heart Damage With Heart Drug and Trastuzumab
News | Cardio-oncology | January 03, 2019
Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage, according to a...